40
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study

, , , , , , , , , , , & show all
Pages 71-80 | Received 05 Oct 2011, Accepted 15 Feb 2012, Published online: 02 Jan 2014

References

  • Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol. 2005;19:799–821.
  • ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomen-clature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.
  • Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood-brain barrier damage as a risk factor for corticosteroid-induced psy-chiatric disorders in systemic lupus erythematosus. Psychoneu-roendocrinology. 2008;33:395–403.
  • Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syn-drome. Semin Arthritis Rheum. 2007;36:297–315.
  • Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Diamond B, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychi-atric lupus erythematosus. Implications for diagnosis and patho-genesis. PLoS ONE. 2008;3:e3347.
  • Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum. 2008;58:843–53.
  • Colasanti T, Delunardo F, Margutti P, Vacirca D, Piro E, Sirac-usano A, et al. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus. J Neuroimmunol. 2009;212:3–9.
  • Efthimiou P, Blanco M. Pathogenesis of neuropsychiatric sys-temic lupus erythematosus and potential biomarkers. Mod Rheumatol. 2009;19:457–68.
  • Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R. Correlation of antibodies to ribosomal P protein with psy-chosis in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992;51:1053–5.
  • Gono T, Kawaguchi Y, Kaneko H, Nishimura K, Hanaoka M, Kataoka S, et al. Anti-NR2A antibody as a predictor for neuro-psychiatric systemic lupus erythematosus. Rheumatology (Oxford). 2011;50:1578–85.
  • Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, et al. Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches. Mol Cell Proteomics. 2011;10:M110.005330.
  • Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 2007;56:938–48.
  • Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med. 2007;204:3221–34.
  • Gono T, Takarada T, Fukumori R, Kawaguchi Y, Kaneko H, Hanaoka M, et al. NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus ery-thematosus. Arthritis Rheum. 2011;63:3952–9.
  • Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005;38:47–54.
  • Maldonado ME, Perez M, Pignac-Kobinger J, Marx ET, Toanan EM, Greidinger EL, et al. Clinical and immunologic manifesta-tions of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population. J Rheuma-tol. 2008;35:429–37.
  • Greidinger EL, Hoffman RW. Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum Dis Clin N Am. 2005;31:437-50, vi.
  • Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, et al. A murine model of mixed connective tissue disease induced with Ul small nuclear RNP autoantigen. Arthritis Rheum. 2006;54:661–9.
  • Greidinger EL, Zang Y, Fernandez I, Berho M, Nassiri M, Martinez L, et al. Tissue targeting of anti-RNP autoimmunity: effects of T cells and myeloid dendritic cells in a murine model. Arthritis Rheum. 2009;60:534–42.
  • Keith MP, Moratz C, Tsokos GC. Anti-RNP immunity: impli-cations for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev. 2007;6:232–6.
  • Greidinger EL, Hoffman RW. The appearance of Ul RNP anti-body specificities in sequential autoimmune human antisera fol-lows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant Ul RNP immunogens. Arthritis Rheum. 2001;44:368–75.
  • Okada J, Hamana T, Kondo H. Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases. Scand J Rheumatol. 2003;32: 247–52.
  • Sato T, Fujii T, Yokoyama T, Fujita Y, Imura Y, Yukawa N, et al. RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum. 2010;62:3730–40.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of sys-temic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 1997;40:1725.
  • Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, et al. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol. 2007;34:2010–7.
  • Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Kanno T, et al. Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study. BMC Musculoskelet Disord. 2010;11:13.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Subcommittee for Scleroderma Criteria of the American Rheu-matism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Thera-peutic Criteria Committee. Arthritis Rheum. 1980;23:581–90.
  • Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis. 1996;55:116–21.
  • Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58:840–6.
  • Katsumata Y, Ridgway WM, Oriss T, Gu X, Chin D, Wu Y, et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun. 2007;29:174–86.
  • Murakami A, Kojima K, Ohya K, Imamura K, Takasaki Y. A new conformational epitope generated by the binding of recom-binant 70-kd protein and Ul RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease. Arthritis Rheum. 2002;46: 3273–82.
  • Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Samma-ritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8.
  • Luyckx A, Westhovens R, Oris E, Papisch W, Bossuyt X. Clin-ical relevance of measurement of antibodies to individual snUl - RNP proteins. Clin Chem. 2005;51:1888–90.
  • Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest. 1992;89:1236–41.
  • Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Sumiya M, Yoko-hari R. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against Ul-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD). Clin Exp Immunol. 1994;98:427–33.
  • Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against Ul-ribonucleoprotein. Clin Exp Immunol. 1999;116: 174–80.
  • Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Takaono M, Iwasaki K, Kinoshita M, et al. Endothelial cell-binding activity of anti-Ul -ribonucleoprotein antibodies in patients with connective tis-sue diseases. Clin Exp Immunol. 2001;126:345–54.
  • Santer DM, Yoshio T, Minota S, Moller T, Elkon KB. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol. 2009;182:1192–201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.